Split thickness donor site wounds Surgery
Conditions
Interventions
Eligible patients will be randomized (blinded using a sealed envelope system) to receive either Suprathel or the current dressing mainly used sterilized Hypafix to their graft site wound as part of th
Sponsors
Mid and South Essex NHS Foundation Trust
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. 65 to 100 years of age 2. Undergoing less than 2% Total Body Surface Area (TBSA) split skin grafting 3. Able to provide informed consent to the study
Exclusion criteria
Exclusion criteria: 1. Patients without the above age range 2. Any allergy to either of the dressings used in the study 3. Patients with any medical condition such as immunosuppression, poorly controlled diabetes or peripheral vascular disease predisposing to altered wound healing
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Time to donor site 95% healed (in days), by visual assessment of total surface area re-epithelialised, confirmed and verified with photographs | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Pain and itch measured using visual analogue scale at 1 week, 2 weeks, and weekly until healed 2. Scar outcome, including colour, relief, vascularity, pliability, and thickness, assessed by patient and observer using Patient and Observer Scar Assessment Scale (POSAS) v2 at the time of healing and week 13 | — |
Countries
England, United Kingdom
Contacts
Public ContactDavid Cussons
Outcome results
None listed